Approval · Notice of Compliance 1077 · 2000
ATACAND: Notice of Compliance 1077
Issued January 28, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1077
- Date
- January 28, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Angiotensin II at1 receptor blocker
Products in this notice
Medicinal ingredients
- CANDESARTAN CILEXETIL 8 MG per TAB
- CANDESARTAN CILEXETIL 16 MG per TAB